NO940524D0 - Kondenserte 5-leddete heterocykler, fremgangsmåte for deres fremstilling, og legemidler inneholdende disse forbindelser - Google Patents
Kondenserte 5-leddete heterocykler, fremgangsmåte for deres fremstilling, og legemidler inneholdende disse forbindelserInfo
- Publication number
- NO940524D0 NO940524D0 NO940524A NO940524A NO940524D0 NO 940524 D0 NO940524 D0 NO 940524D0 NO 940524 A NO940524 A NO 940524A NO 940524 A NO940524 A NO 940524A NO 940524 D0 NO940524 D0 NO 940524D0
- Authority
- NO
- Norway
- Prior art keywords
- condensed
- compounds
- preparation
- membered heterocycles
- drugs containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4304650A DE4304650A1 (de) | 1993-02-16 | 1993-02-16 | Kondensierte 5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO940524D0 true NO940524D0 (no) | 1994-02-15 |
| NO940524L NO940524L (no) | 1994-08-17 |
Family
ID=6480585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO940524A NO940524D0 (no) | 1993-02-16 | 1994-02-15 | Kondenserte 5-leddete heterocykler, fremgangsmåte for deres fremstilling, og legemidler inneholdende disse forbindelser |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0611660A3 (no) |
| JP (1) | JPH072839A (no) |
| AU (1) | AU5513094A (no) |
| CA (1) | CA2115737A1 (no) |
| DE (1) | DE4304650A1 (no) |
| FI (1) | FI940697A (no) |
| IL (1) | IL108648A0 (no) |
| NO (1) | NO940524D0 (no) |
| NZ (1) | NZ250879A (no) |
| ZA (1) | ZA941021B (no) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2751647B1 (fr) * | 1996-07-25 | 1998-09-11 | Synthelabo | Derives de benzimidazole, leurs preparations et leurs applications en therapeutique |
| DE69824029T2 (de) | 1997-10-20 | 2005-05-12 | F. Hoffmann-La Roche Ag | Bicyclische kinase inhibitoren |
| YU64303A (sh) | 2001-02-23 | 2006-05-25 | Merck & Co.Inc. | N-supstituisani nearil-heterociklični antagonisti nmda/nr2b |
| BR0214019A (pt) | 2001-11-09 | 2004-10-13 | Boehringer Ingelheim Phamaceut | Benzimidazóis úteis como inibidores de proteìna quinase |
| AU2003257094A1 (en) | 2002-08-08 | 2004-02-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted benzimidazole compounds |
| ES2524803T3 (es) | 2002-12-19 | 2014-12-12 | The Scripps Research Institute | Composiciones y métodos para estabilizar la transtiretina e inhibir el plegamiento anómalo de la transtiretina |
| EP1479676A1 (en) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | Benzimidazole-derivatives as factor xa inhibitors |
| US7741341B2 (en) | 2003-05-19 | 2010-06-22 | Sanofi-Aventis Deutschland Gmbh | Benzimidazole-derivatives as factor Xa inhibitors |
| TW200517381A (en) | 2003-08-01 | 2005-06-01 | Genelabs Tech Inc | Bicyclic heteroaryl derivatives |
| US20050261365A1 (en) | 2004-05-20 | 2005-11-24 | The Scripps Research Institute | Transthyretin stabilization |
| WO2009086077A2 (en) * | 2007-12-21 | 2009-07-09 | Endacea, Inc. | A1 adenosine receptor antagonists |
| SG2014013270A (en) | 2011-09-16 | 2014-05-29 | Pfizer | Solid forms of a transthyretin dissociation inhibitor |
| EP2956450B1 (en) | 2013-02-14 | 2018-07-25 | Technische Universität München | Hydroxyindalpine derivatives and their medical use |
| US9296754B2 (en) | 2013-03-15 | 2016-03-29 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
| WO2014151630A2 (en) | 2013-03-15 | 2014-09-25 | Irm Llc | Compounds and compositions for the treatment of parasitic diseases |
| AU2014228206C1 (en) | 2013-03-15 | 2018-10-25 | Hydra Biosciences, Llc | Substituted xanthines and methods of use thereof |
| WO2014151729A1 (en) | 2013-03-15 | 2014-09-25 | Irm Llc | Compounds and compositions for the treatment of parasitic diseases |
| SI3083627T1 (sl) | 2013-12-19 | 2019-01-31 | Novartis Ag | Derivati (1,2,4)triazolo(1,5-a)pirimidina kot inhibitorji protozoan proteasoma za zdravljenje parazitskih bolezni, kot je lišmanioza |
| US10112901B2 (en) | 2014-07-03 | 2018-10-30 | Shanghai Institute Of Pharmaceutical Industry | Method for preparing dabigatran etexilate intermediate, and intermediate compound |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2208367B (en) | 1987-07-09 | 1991-07-03 | Alcatel Business Systems | Franking machine |
| US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
| DE4124942A1 (de) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE4129603A1 (de) * | 1991-09-06 | 1993-03-11 | Thomae Gmbh Dr K | Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE4214245A1 (de) * | 1992-04-30 | 1993-11-04 | Thomae Gmbh Dr K | Tritiummarkierte fibrinogen-rezeptor-antagonisten, deren verwendung und verfahren zu ihrer herstellung |
| ES2092170T3 (es) * | 1992-04-28 | 1996-11-16 | Thomae Gmbh Dr K | Antagonistas de receptores de fibrinogeno marcados con tritio, su utilizacion y procedimiento para su preparacion. |
-
1993
- 1993-02-16 DE DE4304650A patent/DE4304650A1/de not_active Withdrawn
-
1994
- 1994-02-14 JP JP6017568A patent/JPH072839A/ja active Pending
- 1994-02-14 EP EP9494102222A patent/EP0611660A3/de not_active Withdrawn
- 1994-02-15 FI FI940697A patent/FI940697A/fi not_active Application Discontinuation
- 1994-02-15 NO NO940524A patent/NO940524D0/no unknown
- 1994-02-15 ZA ZA941021A patent/ZA941021B/xx unknown
- 1994-02-15 NZ NZ250879A patent/NZ250879A/xx unknown
- 1994-02-15 CA CA002115737A patent/CA2115737A1/en not_active Abandoned
- 1994-02-15 AU AU55130/94A patent/AU5513094A/en not_active Abandoned
- 1994-02-15 IL IL10864894A patent/IL108648A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU5513094A (en) | 1994-08-18 |
| FI940697A0 (fi) | 1994-02-15 |
| DE4304650A1 (de) | 1994-08-18 |
| CA2115737A1 (en) | 1994-08-17 |
| FI940697A (fi) | 1994-08-17 |
| ZA941021B (en) | 1995-08-15 |
| IL108648A0 (en) | 1994-05-30 |
| JPH072839A (ja) | 1995-01-06 |
| NO940524L (no) | 1994-08-17 |
| NZ250879A (en) | 1995-09-26 |
| EP0611660A3 (de) | 1994-09-14 |
| EP0611660A2 (de) | 1994-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI940378A (fi) | 5-jäseniset heterosyklit, menetelmä niiden valmistamiseksi ja näitä yhdisteitä sisältävät lääkeaineet | |
| NO940524D0 (no) | Kondenserte 5-leddete heterocykler, fremgangsmåte for deres fremstilling, og legemidler inneholdende disse forbindelser | |
| NO933248D0 (no) | Cykliske urinstoffderivater, legemidler inneholdende disse forbindelser, og fremgangsm}te for deres fremstilling | |
| DK0807111T3 (da) | Substituerede heterocykliske forbindelser, fremgangsmåde til fremstillingen heraf samt farmaceutiske sammensætninger indeholdende disse | |
| NO924027D0 (no) | Heterobiarylderivater, legemidler inneholdende disse forbindelser, og fremgangsmaate for deres fremstilling | |
| NO308738B1 (no) | Bicyklisk kondenserte pyridiner, legemidler inneholdende disse og anvendelse av forbindelsene for fremstilling av legemidler | |
| ZA926700B (en) | Condensed 5-membered heterocyclic compounds processes for preparing them and pharmaceutical preparations containing these compounds | |
| NO934501D0 (no) | Karboksylsyrederivater, legemidler inneholdende disse forbindelser, og fremgangsmaat e for deres fremstilling | |
| NO984084D0 (no) | 4-Amino-pyrimidin-derivater, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte ved fremstilling derav | |
| NO932120D0 (no) | Bifenylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling | |
| DK231687D0 (da) | Heterocykliske forbindelser, deres fremstilling og anvendelse, samt laegemidler indeholdende disse forbindelser | |
| DK0489647T3 (da) | N,O-sulfaterede heparosaner, fremgangsmåde til fremstilling heraf og lægemidler indeholdende disse forbindelser. | |
| DK162491D0 (da) | Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne | |
| NO305398B1 (no) | Tiosubstituerte nitrogenholdige heterocykliske fosfonatforbindelser, og anvendelser derav | |
| DK166279C (da) | 3,4-dihydro-2h-benzooebaapyranderivater, deres fremstilling og laegemidler indeholdende disse forbindelser | |
| NO932636L (no) | Benzimidazoler, medikamenter inneholdende disse forbindelser, og fremgangsmaate for deres fremstilling | |
| NO974934D0 (no) | 10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmåte for deres fremstilling og legemidler som inneholder disse forbindelsene | |
| DK102990D0 (da) | Thieno-triazolodiazepinderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse | |
| NO930796D0 (no) | Glykopeptidderivater, fremgangsmaate for deres fremstilling og farmasoeytiske midler inneholdende disse | |
| NO934633D0 (no) | Kondenserte, heterocykliske forbindelser, deres fremstilling og anvendelse | |
| NO933558D0 (no) | Benzimidazoler, legemidler inneholdende disse forbindelser, og fremgangsmaate for deres fremstilling | |
| DK553689A (da) | Phenyloxypropanolaminderivater, fremgangsmaade til fremstilling af saadanne forbindelser samt laegemiddel indeholdende disse | |
| DK291189A (da) | Kondenserede diazepinoner, fremgangsmaade til fremstilling af saadanne forbindelser og laegemidler med indhold af forbindelserne | |
| NO20000182L (no) | Fremgangsmåte for fremstilling av alkoksyfuranonamin- derivater, forbindelser frembragt ved fremgangsmåten og anvendelse av disse forbindelser | |
| NO871375D0 (no) | Bis-tertiaerbutylamino-substituerte 1,3,5-triazinderivater, fremgangsmaate til deres fremstilling, legemidler inneholdende disse forbindelser og deres anvendelse. |